Skip to main content
. 2016 Jan 12;81(4):646–657. doi: 10.1111/bcp.12815

Figure 1.

Figure 1

Schematic representation of the workflow of physiologically based pharmacokinetic (PBPK) model development. B/P, blood to plasma ratio; CL, clearance; Dcot, diffusion (cotyledon); Dpl, diffusion (placenta); F, bioavailability; fu, free fraction; GFR, glomerular filtration rate; ka: absorption rate constant; KpPL, placental partition coefficient, kPE, placental elimination; MW, molar mass; Phys‐chem, physicochemical; PK, pharmacokinetic